Ois Podcast

In this double-feature episode of the OIS Eye on Innovation Podcast, Carey Powers highlights the invaluable resources and expertise within the OIS community, showcasing the power of cross-collaboration and strategic foresight in biotech.Part 1: Dr. Francis Lasowski (C20/20 Innovation Hub) and Dr. Wendy Naimark (Ripple Therapeutics) discuss their long-standing partnership, which has propelled Ripple's success through groundbreaking innovations, including dry AMD research and key advancements in IP management. Learn how the Innovation Hub provides early-stage companies with critical resources to navigate the challenges of development and commercialization.Part 2: Tracy Valorie, a biotech and pharma veteran, explains why early commercial strategy is the key to success. From understanding market access and reimbursement to planning for manufacturing readiness, Tracy shares actionable tips for startups to avoid costly mistakes and maintain a commercial mindset throughout product development.In this episode, y

In this episode of The Rob and Jai Show from OIS XIV, hosts Dr. Rob Rothman and Dr. Jai Parekh talk with Eric Schlumpf, CEO of Stuart Therapeutics, about the company’s transformative approach to ophthalmic diseases. Learn how Stuart's innovative polypeptide technology repairs damaged collagen, advancing from dry eye to neuroprotection in glaucoma and beyond. Eric highlights key milestones, including promising clinical trial results, strategic partnerships, and the company’s plans to tackle major unmet needs like myopia and inherited retinal diseases.In this episode, you’ll learn:How Stuart Therapeutics’ polypeptide platform is revolutionizing ophthalmic treatments.The potential for neuroprotection in glaucoma and what makes Stuart’s approach unique.Why Stuart’s dry eye clinical program could be a market differentiator.The exciting data supporting new indications like myopia and inherited retinal disease.How strategic partnerships are fueling innovation in a capital-efficient way.Tune in for an engaging c

Carey Powers caught up with five innovative companies at this years OIS XIV in San Diego, to discuss the latest advancements in ophthalmology on the OIS podcast.Topics included touchless laser therapy for presbyopia, extending the duration of intravitreal treatments, next-generation tear fluid testing, and new imaging methodologies for vitreoretinal conditions. Guests include:Alex Lopez, Chief Commercial Officer - Ace Vision GroupHouman Hemmati, MD, PhD, Co-Founder & Chief Medical Officer - Optigo BiotherapeuticsLeanne Lavriola, DO, MBA, President & CEO - InnSight TechnologyNir Katchinskiy, PhD, CEO & Co-Founder - PulseMedica

In this episode, listen in as Dr. Robert Rothman speaks with Dr. Daniel Brocks, CMO of BostonSight! They discuss the unique PROSE lenses that are redefining corneal care and how BostonSight’s nonprofit mission is making advanced treatments accessible to more patients. Key takeaways include:PROSE Lenses: Customized scleral lenses that protect, hydrate, and restore vision for complex eye conditions.Increased Accessibility: BostonSight’s new tech-driven approach to simplify lens fitting for broader use.Mission-Driven Impact: How BostonSight reinvests revenue to offer free care and support for patients in need.Join us to learn more about these innovations and the future of specialty eye care—tune in now!

In this episode of the OIS Retina Podcast, Firas Rahhal sits down with Jean-Pierre Hubschman, CEO of Horizon Surgical, to discuss the revolutionary advancements in robotic eye surgery. Highlights include:The development of the "IRISS" robotic platform and its focus on cataract surgery.Insights into AI-driven precision, decision-making, and visualization in surgery.Challenges of transitioning from academia to a successful medtech startup.Future potential for robotics in glaucoma, retina, and other ophthalmic procedures.Listen now to hear how AI and robotics are transforming eye surgery!

In this episode of the OIS Podcast, host Rob Rothman sits down with Jay Cormier, CEO of Eyedaptic, to explore innovative solutions for individuals with vision loss. They discuss Eyedaptic's groundbreaking technology and its impact on enhancing daily life for those with visual impairments.Key Highlights:Insight into the inspiration behind Eyedaptic and its mission to improve independence for the visually impaired.Overview of the EYE5 product, an augmented reality solution that enhances mobility and connection to the environment.Discussion on the recent launch of Ivy, an AI visual assistant that transforms user interaction with their surroundings.Importance of targeted marketing and in-person demos for increasing accessibility to Eyedaptic’s products.Join us to discover how Eyedaptic is revolutionizing the way we think about vision care!

In this week’s OIS Podcast episode, Host Dr. Robert Rothman sits down with Almog Aley-Raz, CEO of CorNeat Vision, for a fascinating discussion. They cover:Almog’s career journey from Israel to the U.S.How a mountain biking trip with an ophthalmologist sparked the idea for CorNeat VisionCorneal blindness as a global issue and the need for better solutions, especially in regions with limited donor tissue and trained surgeonsCorNeat's groundbreaking synthetic cornea, made with their unique material, Avatrix, which offers exciting potential for restoring visionApplications of Avatrix beyond ophthalmology, including maxillofacial and dental proceduresTune in now to learn more!

Exciting insights from the OIS Retina Panel! Moderated by Dr. Emmett Cunningham, this discussion dives deep into the current state of ophthalmology investment and innovation. Panelists, Anna Chen, Adit Ghosh, Dr. Firas Rahhal and Caroline Stout shared their perspectives on the evolving landscape, highlighting both opportunities and challenges in the field.Here are the key takeaways:Cautious Optimism: A resurgence in private markets, but drug development challenges persist.Growth Areas: Focus on drug delivery, extended-release biologics, and complement inhibitors for dry AMD/GA.Strategic Partnerships: Crucial for commercialization in ophthalmology.Emerging Trends: AI’s potential impact and regulatory changes in drug discovery.Market Concerns: Uncertainties around gene therapy and commercial viability.Don’t miss out—listen in now to gain valuable insights!

Don’t miss the OIS Retina Panel, moderated by Dr. Pravin Dugel, “The View from the Street.” Join Dr. Anupam Dalal, Andrew Gitkin, and Cameron Taylor as they discuss the latest in ophthalmology, including:Current Challenges: Few blockbuster drugs and limited M&A activityOpportunities: Growth potential from recent GA therapy successesStrategic Insights: Importance of community and networkingGet valuable insights from industry experts and stay ahead of the curve. Listen in now!

Discover the milestone 400th episode of the OIS podcast with Dr. Firas Rahhal and Dr. Robert Rothman, where they explore the impact of Ophthalmology Innovation Summit (OIS) on the investment ecosystem:Journey of OISRich InsightsCollaborationClinical MasteryLong-Term RelationshipsHumor and AdmirationFuture of OphthalmologyTune in to this episode for a blend of knowledge, inspiration, and laughter as they navigate the future of eye care innovation. Don’t miss out—listen now!

In this episode of Eye on Innovation Podcast, Carey Powers delves into the latest advancements in corneal crosslinking technology with expert guest Dr. Deepinder Dhaliwal. Dr. Dhaliwal, a renowned professor of ophthalmology at the University of Pittsburgh School of Medicine and director of refractive surgery at the UPMC Vision Institute, shares her extensive knowledge and insights. Here’s what you can expect:Prevalence of Keratoconus: Discover how improved diagnostic imaging has revealed a higher prevalence of keratoconus than previously thought, affecting 1.2% of 20-year-olds.Current Standard of Care: Learn about the FDA-approved epithelium-off crosslinking procedure and its role in treating progressive keratoconus in the U.S.Unmet Needs in Treatment: Understand the challenges of current crosslinking procedures, including patient discomfort, long recovery times, and the need for safer, faster options.Innovative Solutions: Get insights into upcoming advancements like epithelium-on crosslinking, which promises

In our latest episode, host Dr. Rob Rothman interviews Greg Kunst, CEO of Aurion Biotech, to delve into the forefront of cell therapy for corneal disease. Join us to discover:Greg's journey from pivotal roles at Alcon and Glaukos to leading Aurion BiotechThe innovative allogenic cell therapy technology developed by AurionHow this technology addresses the global shortage of corneal tissueInsights into the challenges and breakthroughs in scaling production and securing market approvalFuture applications of cell therapy in ophthalmology beyond corneal endothelial diseaseDon't miss this fascinating conversation on the future of medical innovation in ophthalmology! Listen to the episode and subscribe to the OIS Podcast for more updates on the latest trends in eye care and medical technology.

This week's OIS Podcast features a compelling panel discussion from the Dry Horizons Symposium co-presented by Ora and OIS, held on May 3 in Seattle. The panel, comprising leading experts in ophthalmology and dry eye research, covered essential topics in the field:

Explore the cutting-edge world of ophthalmology with the Eye on Innovation Podcast. In the latest episode, Carey Powers hosts Dr. Rishi Singh and Dr. Michael Singer as they delve into how AI and robotics are transforming retina medicine, bringing unprecedented changes to diagnosis, clinical trials, and patient care. This insightful discussion provides valuable information for ophthalmologists, researchers, and anyone interested in the future of eye care. Here’s what you can expect from this episode:AI in Diagnostics: Learn how AI technology is streamlining and enhancing the accuracy of retina diagnostics through devices like Optical Coherence Tomography (OCT).Robotics in Surgery: Discover the challenges and opportunities of integrating robotics into retinal surgery, and what the future might hold for these advanced surgical techniques.Improved Clinical Trials: Find out how AI is enabling better patient selection and more efficient clinical trial processes, leading to potentially better outcomes.FDA Regulation

In this compelling OIS podcast episode, host Dr. Rob Rothman engages in an insightful conversation with Dr. Malvina Eydelman, the Director of the FDA's Office of Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices. Delve into Malvina's unique career journey and discover how her diverse background in engineering and ophthalmology has influenced her work at the FDA. Here's what you can expect from this episode:Malvina's Journey: Learn how Malvina went from growing up in Georgia to becoming a key leader at the FDA, thanks to her strong engineering and medical background.FDA's Role in Innovation: Discover how the FDA is evolving to support innovation, with a focus on collaborative workshops and clear standards for ophthalmic devices.Leadership During COVID-19: Hear about Malvina's critical role during the COVID-19 pandemic, managing the rapid approval and production of ventilators and respiratory devices.Tips for Early Engagement with the FDA: Get valuable advice on how to n

In the latest episode of the OIS podcast, host Dr. Rob Rothman delves into the transformative power of empathy with multi-Emmy award-winning actress and writer, Ellen Gould. Together, they explore the intersection of healthcare and storytelling, shedding light on the importance of patient-centered care and authentic narrative representation.Episode Highlights:Personal Journey: Ellen shares her journey living with Stargardt's disease and its profound influence on her perspective and creative endeavors.Adversity to Opportunity: Discover how Ellen turned personal challenges into opportunities for artistic expression and meaningful storytelling."Seeing Stars" Project: Get an inside look at Ellen's groundbreaking project, which amplifies the voices and experiences of individuals with visual disabilities.Authentic Storytelling: Rob and Ellen discuss the importance of authentic storytelling in portraying the real-life challenges and triumphs of people with disabilities.Future Outlook: Hear about

In this episode, Dr. Jai Parekh shares his journey from ophthalmology to business leadership in healthcare. Raised in New Jersey, he initially pursued cardiology before discovering his passion for ophthalmology. Specializing in cornea and refractive surgery, he transitioned into the commercial side of the field, leveraging his clinical expertise and business acumen.Key points covered in the episode include:Transition into the commercial side of ophthalmology, leveraging clinical expertise and business acumen.Emphasis on the importance of physicians in shaping the healthcare industry and bridging the gap between clinical practice and business.Dedication to continuous learning, interdisciplinary collaboration, and innovation in advancing patient care and the field of ophthalmology.Don't miss out on this exclusive opportunity to learn from a visionary leader in the field!

Don't miss the latest episode of the OIS Retina Podcast, where we sit down with optometrist and ophthalmology researcher Brian Levy for an illuminating discussion on the future of eye care. In this episode, Brian takes us on a journey through his career, from his early days in vet school to his groundbreaking work at Presbyterian Medical Center, Aerie Pharmaceuticals, Bausch + Lomb and currently at InflammX Therapeutics. Here are some key talking points from the episode: 

Tune in to the latest episode of the Eye On Innovation podcast where Carey Powers dives into the dynamic world of biotech investor pitch decks with special guest Dr. Rob Rothman, Founding Partner of InFocus Capital Partners. Discover the top five mistakes to avoid when crafting your pitch deck and gain exclusive insights from Dr. Rothman's wealth of experience in ophthalmology and venture capital.In this episode, you'll learn:The importance of tailoring your pitch deck to specific investors.Strategies for keeping your pitch deck concise and engaging.Why it's crucial to address challenges, competition, and reimbursement in your presentation.The art of storytelling and its impact on investor engagement.Don't miss out on this enlightening discussion—subscribe to the OIS podcast today and stay ahead of the curve in biotech innovation!

Join us this week on the OIS podcast as host Carey Powers sits down with Dr. Paul Karpecki to explore the latest advancements in presbyopia treatment strategies. Here's what you can expect from this insightful conversation:Insider Insights: Dr. Karpecki shares insider insights gleaned from his extensive clinical experience and research in the field of presbyopia treatment.Financial Potential: Discover the potential for unprecedented financial gains in the rapidly evolving market of presbyopia treatment.Cutting-Edge Strategies: Uncover the latest cutting-edge strategies and developments in the treatment of presbyopia, offering hope and solutions to millions affected by this common eye condition.Tune in to this episode for an in-depth look at the future of presbyopia treatment and the exciting opportunities it presents!